Live Breaking News & Updates on Chana Weinstock

Stay updated with breaking news from Chana weinstock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

'Nothing Rivaled This': Navigating the Cancer Drug Shortage

Because this platinum drug shortage crisis won't be the last, oncology practices need to be better prepared to tackle future problems. ....

United States , Maurie Markman , Elizabetha Guancial , Chana Weinstock , American Cancer Society Action Network , American Society Of Clinical Oncology , Office Of Oncology Products , Florida Cancer Specialists Research Institute , Drug Administration , Florida Cancer Specialists , Research Institute , American Society , Clinical Oncology , Medscape Medical ,

FDA Panel Votes Proposed Olaparib/Abiraterone Indication Should Be Restricted to BRCA-Mutant mCRPC

In an 11-to-1 vote, the FDA’s Oncologic Drugs Advisory Committee voted that the proposed indication of olaparib in combination with abiraterone acetate and prednisone or prednisolone for the initial treatment of patients with metastatic castration-resistant prostate cancer should be restricted to those whose tumors harbor a BRCA mutation. ....

United States , Chana Weinstock , Ashley Rosko , Division Of Oncology , Oncologic Drugs Advisory Committee , University Of Colorado Cancer Center , Office Of Oncologic Diseases , Gi Medical Oncology Program , Ohio State University Comprehensive Cancer Center , Drugs Advisory Committee , Christopher Lieu , Oncology Program , Colorado Cancer Center , Oncologic Diseases , Oncologic Drugs Advisory Committee , Prostate Cancer , Castration Resistant Prostate Cancer , Abiraterone Acetate ,

FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC

ODAC votes that olaparib-abiraterone combination should be restricted to <em>BRCA</em>-positive subset ....

United States , North Carolina , Columbia University , New York , Mike Bassett , Chana Weinstock , Daniel George , Los Angeles , Richard Pazdur , Neil Vasan , Jorge Nieva , Astrazeneca Laurence Toms , Duke Cancer Institute In Durham , Columbia University Medical Center , Oncology Center , Office Of Oncologic Diseases , University Of Colorado Cancer Center , Oncologic Drugs Advisory Committee , Christopher Lieu , Colorado Cancer Center , New York City , Oncologic Diseases , Southern California , Keck School , Laurence Toms , Duke Cancer Institute ,